University of South Florida

Digital Commons @ University of South Florida
USF Tampa Graduate Theses and Dissertations

USF Graduate Theses and Dissertations

April 2022

Bioactivity of Suberitenones A and B
Jared G. Waters
University of South Florida

Follow this and additional works at: https://digitalcommons.usf.edu/etd
Part of the Chemistry Commons

Scholar Commons Citation
Waters, Jared G., "Bioactivity of Suberitenones A and B" (2022). USF Tampa Graduate Theses and
Dissertations.
https://digitalcommons.usf.edu/etd/9495

This Thesis is brought to you for free and open access by the USF Graduate Theses and Dissertations at Digital
Commons @ University of South Florida. It has been accepted for inclusion in USF Tampa Graduate Theses and
Dissertations by an authorized administrator of Digital Commons @ University of South Florida. For more
information, please contact scholarcommons@usf.edu.

Bioactivity of Suberitenones A and B

by

Jared G. Waters

A thesis submitted in partial fulfillment
of the requirements for the degree of
Master of Science
Department of Chemistry
College of Arts and Sciences
University of South Florida

Major Professor: Bill Baker, Ph.D.
James Leahy, Ph.D.
Michael Teng, Ph.D.
H. Lee Woodcock, Ph.D.

Date of Approval:
March 25, 2022

Keywords: Natural products, drug discovery, sponges
Copyright © 2022, Jared G. Waters

Dedication
I would like to dedicate this thesis to my mother, Stacey Waters, a calm and gentle soul
who has taught me the importance of patience and enjoying the small moments in life. My
father, Frank Waters, who instilled in me a sense of confidence and ambition in life. My
brother, Sean Waters, for always being there for me and always finding a way to make me
laugh and forget all of my worries. My best friends, Willa Qu and Sarah Dietrick, for always
making me laugh and smile even at the most stressful of times. And finally, my darling Lauren
Smith, for bringing so much joy to my life and being endlessly patient as I write this thesis.

“I know that I know nothing.” - Socrates

Acknowledgements
Firstly, I’d like to thank my advisor, Dr. Bill Baker. His guidance, insight, and patience
were invaluable. His expertise in his field was inspirational. But most importantly, his genuine
zeal for life and appreciation for the little things we enjoy day to day make him a model to look
up to. He not only taught me a tremendous deal about chemistry and natural products, but also
to never lose sight of why we find such things so endlessly fascinating, and to never let the
daunting task of studying such topics make us lose our appreciation of the fun and adventure
life has to offer.
I’d like to thank the labs of Dr. Lindsey Shaw and Dr. John Adams for conducting the
ESKAPE and malaria bioassays respectively. The data they were able to gather was invaluable to
this research, and their assistance was greatly appreciated.
I’d also like to thank my fellow graduate students in the Baker Lab. They were like a
second family to me. They were both a source of academic guidance, as well as many laughs
along this long and arduous journey. Of particular note, I’d like to thank Joshua Welsch and
Sofia Kokkaliari. Their guidance and tutelage in the use of the various instruments we utilize in
our research was invaluable. Additionally, I’d like to thank Sarah Dietrick for conducting the
Candida albicans and Candida auris bioassays, as well as always having my back and being
someone I can depend on and for helping me in the process of writing this thesis.

Finally, I’d like to thank my family; my parents and my older brother. I wouldn’t have
made it as far in life as I have without their support and motivation. Their encouragement was
of tremendous help in making my way through my time as a graduate student, and in the
writing of this thesis.

Table of Contents
1. Natural Products ........................................................................................................1
1.1 What is a natural product? ......................................................................1
1.2 History of Natural Products in Medicine .................................................2
1.3 Antarctica .................................................................................................6
1.4 Sea Sponges as a Source of Natural Product ...........................................8
2. Chemical Investigation of Suberites sp ......................................................................13
2.1 Medical Impact of Sponge Metabolites ...................................................13
2.2 Experimental Procedure ..........................................................................14
3. Results and Conclusion ..............................................................................................16
3.1 Experimental Data ...................................................................................16
3.2 Conclusion ................................................................................................23
4. References .................................................................................................................24

i

List of Tables
3.1

Comparison of experimental NMR values of Suberitenone A to literature values...........18

3.2

Comparison of experimental NMR values of suberitenone B to literature values...........19

3.3

Table provided by Dr. Adams’ lab of IC50 and cytotoxicity values of suberitenones
compared to known anti-malarial compounds.................................................................22

ii

List of Figures
1.1

An example of a cardenolide……………………..…………………………………………………………………..2

1.2

Chemical structure of morphine……………………..………………..……………………………………………3

1.3

Cordycepin…………………………..…………………………………………………………………………………..……4

1.4

Chemical structure of salicin…………………………………………………………………………………………..5

1.5

Chemical structure of salicylic acid and acetylsalicylic acid………………..…………………………..6

1.6

A diagram of the Antarctic Circumpolar Current……………………………………………....……………7

1.7

The chemical structure of darwinolide...............................................................................9

1.8

Chemical structures of (−)-(1R,2R,6R,8S,6’S)-discorhabdin B dimer and (−)(1S,2R,6R,8S,6’S)-discorhabdin B dimer............................................................................11

1.9

Chemical structures of suberitenone A and suberitenone B............................................12

2.1

A freeze dried Suberites sp...............................................................................................14

3.1

Generic suberitenone structure with position numbering system used by Shin, et al.....17

3.2

Graph provided by Dr. Shaw’s lab displaying the %Inhibition of suberitenones A and B
against ESKAPE pathogens................................................................................................21

iii

List of Schemes
2.1 Extraction Scheme for Suberites sp. (sample PSC18-106)…………………………………………………..16

iv

List of Abbreviations and Units
sp.

species

Na

sodium

K

potassium

ATP

adenosine triphosphate

BCE

before common era

ACC

Antarctic circumpolar current

IC50

Half-maximal inhibitory concentration

μM

micromolar

HaCaT

cultured human keratinocyte cells

CETP

cholesterol ester transfer protein

ESKAPE

Enterococcus faecium, Staphylococcus
aureus, Klebsiella pneumoniae,
Acinetobacter baumannii, Pseudomonas
aeruginosa, Enterobacter spp.
dichloromethane

DCM

nuclear magnetic resonance

NMR

v

ELS

Evaporating Light Scattering

HPLC

high performance liquid chromatography

C18

octadecyl bonded silica

%

percent

mg

milligram

ppm

parts per million

DHA

dihydroartemesinin

MPLC

Medium Pressure Liquid Chromatography

UV

Ultraviolet

vi

Abstract
Throughout human history, natural products have formed the foundation of medicine.
In ancient times, a myriad of herbs and fungi have been attributed properties of healing and
rejuvenation. Today, that foundation still very much exists, as natural product chemists isolate
bioactive compounds from plants, fungi, animals, and microorganisms alike. As more of these
secondary metabolites are discovered, scientists pursue more and more sources of biodiversity
that may yield new and unprecedented compounds.
To this end, Antarctica has become of particular note, as its unique environmental
conditions and highly isolated nature make for rare and unusual adaptations in its native
wildlife. Although the actual landmass of Antarctica is rather desolate, the surrounding water is
teeming with life. Sponges, corals, algae, and a wide variety of other organisms call the
Southern Ocean home, and they have provided scientists a whole host of new and novel
compounds. In particular, this thesis is focused on investigating the sponge Suberites sp. and a
pair of compounds previously isolated from it known as suberitenone A and suberitenone B,
which exhibit the potential for bioactivity.
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Chapter 1: Introduction

1.1 What is a natural product?
Life, in all its various forms, is comprised of fundamental building blocks known as
metabolites. Whether it be proteins, lipids, nucleic acids, or carbohydrates, the various
components of our being are comprised of these basic chemical units. Many metabolites play a
vital role in our body’s ability to sustain itself, taking part in the metabolic pathways responsible
for homeostasis. These are known as primary metabolites. However, some metabolites do not
take part in these biochemical processes, and instead play a role in an organism’s survival
within their ecological niche. Derived chemically from primary metabolites, these compounds
are known as secondary metabolites,1 otherwise referred to as “natural products”.
An example of natural products in nature is the family of chemicals collectively referred
to as cardenolides (Figure 1.1). These compounds are produced naturally within members of
the plant genus Asclepias, more commonly known as Milkweeds. Milkweeds produce these
compounds not as a means of fueling their metabolism, or as building blocks for their own
growth, but rather as a chemical defense against herbivores.2 Cardenolides, when ingested,
function as inhibitors of Na+/K+ ATPase.3 This inhibition will, in many species, result in cardiac
arrest, deterring most would-be consumers from eating milkweed. This is but one of many
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examples of natural products. Be they poisons to deter predation, pheromones to attract
mates, or chemical defenses against infection, secondary metabolites possess all manner of
forms and functions.

Figure 1.1 An example of a cardenolide.4
1.2 History of Natural Products in Medicine
Humanity’s utilization of natural products for medicinal purposes dates back millennia.
Records from 4000 BCE from ancient Sumer exist that describe the use of the plant Papaver
somniferum, more commonly known as the poppy, for medicinal purposes.1 In the modern day,
we now know that the poppy naturally produces morphine (Figure 1.2) as a secondary
metabolite, a trait that earned it the name “joy plant” among the ancient Sumerians.

Figure 1.2 Chemical structure of morphine.5
2

Meanwhile, the people of ancient Tibet made medicinal use of a parasitic fungus, known
today as Ophiocordyceps sinensis.6 Known to the Tibetans as “winter worm, summer grass”, this
entomopathogenic fungus produces a variety of secondary metabolites that aid in the
treatment of numerous medical issues. These include anti-inflammatory effects, antioxidants,
and even anti-cancer activity.7 One such natural product that is actually named for the
Cordyceps genus is cordycepin (Figure 1.3), a compound that displays potential for anticancer activity.7

Figure 1.3 Chemical structure of cordycepin.7
The list of plants, fungi, etc. used by humans for more than just food and building
materials goes on and on throughout the ages. As humanity’s knowledge of chemistry has
grown more advanced into the modern day, our ability to discover, isolate, and modify such
compounds has improved greatly. A good example of this is the development of acetylsalicylic
acid, otherwise known as aspirin. Aspirin has its origins in the chemical compound salicin
(Figure 1.4), a secondary metabolite found in the Salix genus of plants, more commonly known
as willows. Salicin, when metabolized by the body, produces salicylic acid, which has anti3

inflammatory properties. As such, willow has been used as early as 4000 BCE for ailments such
as joint pain and fever.8 Despite the millennia of willow’s use for medicinal purposes, salicin
would not be isolated until 1829, by a French pharmacist named Henri Leroux. It would then
take several more years for scientists to successful convert salicin into salicylic acid.8

Figure 1.4 Chemical structure of salicin.9
Although salicylic acid is an effective anti-inflammatory, it is irritating to the
gastrointestinal tract, resulting in nausea when consumed. This led to the desire to find a
functionally equivalent chemical that didn’t have such adverse side-effects. This culminated in
Felix Hoffman modifying salicylic acid through chemical synthesis in 1893, creating
acetylsalicylic acid (Figure 1.5), better known as aspirin.8 The acetylation of salicylic acid
reduced its irritating qualities, while preserving its anti-inflammatory properties.

4

Figure 1.5 Chemical structure of salicylic acid (left) and acetylsalicylic acid (right).9
As the years have gone on since, many other natural products have been isolated, and
then further modified through chemical synthesis in order to either augment their medicinal
properties, or to reduce their adverse effects on the human body.
1.3 Antarctica
Although many regions and climates are home to a variety of novel natural products,
Antarctica has become something of a hot spot for secondary metabolites. This is due to
Antarctica’s extreme and highly isolated environmental conditions, requiring organisms native
to the region to utilize unusual adaptations to survive. A major component of Antarctica’s
highly isolated nature is the Antarctic Circumpolar Current (ACC). This powerful current flows
eastward in a circular fashion around the Antarctic continent, isolating the Southern Ocean
from neighboring bodies of water10 (Figure 1.6). This current prevents the warmer waters of
lower latitudes from flowing southward towards Antarctica, playing a role in the continent’s
glacial climate.

5

Figure 1.6 A diagram of the Antarctic Circumpolar Current.10
The isolated nature of Antarctica’s ecosystems is further reinforced by its periods of
glaciation. Throughout our planet’s history, there has been a repeated cycle of global warming
and cooling. During periods of cooling, glaciation events have occurred, with landmasses and
bodies of water freezing over. While much of the Earth’s ecosystems experienced reduced
biodiversity during these glaciation events, the opposite occurred in Antarctica.11 While
coastal waters may have frozen over, deeper waters would have been spared, creating safe
havens for costal populations to migrate too. These pockets of life would then find themselves
isolated from one another, separated by physical barriers in the form of ice sheets. Thus, these
safe havens would become self-contained ecosystems, with their own food webs being
established over time.
As the years would pass, these isolated communities of previously homogenous
organisms would diverge genetically in order to adapt to their current safe haven. Then, after
much time had passed, the Earth would transition into a period of global warming. This would
6

cause the ice sheets to recede, and these isolated communities would now be able to interact
with one another. Organisms from varied ecosystems would be able to interbreed and compete
with one another, generating a host of new selective pressures. This cycle of glaciation,
isolation, warming, and intermingling would repeat itself multiple times throughout Earth’s
history, resulting in a significant degree of speciation and genetic drift.
1.4 Sponges as a Source of Natural Products
Although natural products can be found in a wide variety of different organisms, sessile
organisms are of particular note. While mobile organisms can avoid predation or sources of
stress by vacating the area, sessile organisms lack the luxury of movement. Thus, many sessile
organisms rely heavily on chemical defenses against would-be predators or other ecological
stressors. For these reasons, an abundance of natural products can be found in organisms such
as cnidarians, tunicates, and sponges.12
One such example of an Antarctic sponge producing natural products is Dendrilla
membranosa. A brightly colored yellow sponge found in multiple regions around the Antarctic
coast, D. membranosa has been observed to not be preyed upon nearly as often as other
sponges. This led scientists to believe it possessed some manner of chemical defense against
predators.13 Upon investigation, the sponge was found to produce multiple secondary
metabolites of interest. One natural product of particular note is darwinolide (Figure 1.7), a
diterpene that was tested against biofilms produced by Staphylococcus aureus.14 A biofilm is a
large colony of microorganisms adhered together by an extracellular matrix produced by those
organisms. This polysaccharide and protein-based matrix helps to protect bacteria from many
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forms of treatment, with biofilms being estimated to be responsible for up to 80% of
bacterial infections.14
With this in mind, darwinolide was tested as a possible anti-biofilm agent. The results
were promising, with only 1.6 percent of the bacteria able to recover from the darwinolide
treatment. Darwinolide was found to be cytotoxic against S. aureus, with an IC50 of 33.2 μM,
while lacking in cytotoxicity against mammalian cells, with an IC50 of 73.4 μM. With this
information, it would appear that darwinolide is a promising biofilm-specific antibiotic.14

Figure 1.7 The chemical structure of darwinolide.14
In 2020, the Antarctic sponge Latrunculia biformis was investigated. The sponge was
found to produce multiple secondary metabolites known as discorhabdins, with two of them
being new structures. The known compound was (−)-(1R,2R,6R,8S,6’S)-discorhabdin B dimer,
while the two new molecules were (−)-(1S,2R,6R,8S,6’S)-discorhabdin B dimer and (−)(1R,2R,6R,8S,6’S)-16’,17’-dehydrodiscorhabdin B dimer15 (Figure 1.8). These molecules were
8

immediately noteworthy as dimeric discorhabdins are far more rare in the natural world than
monomeric discorhabdins. Unfortunately, (−)-(1R,2R,6R,8S,6’S)-16’,17’-dehydrodiscorhabdin B
dimer could not be isolated in large enough amounts to effectively test its bioactivity, but (−)(1R,2R,6R,8S,6’S)-discorhabdin B dimer and (−)-(1S,2R,6R,8S,6’S)-discorhabdin B dimer were
able to be tested against human colon cancer cell lines. They were found to have great
potential against the colon cancer cells, with the former having an IC50 value of 0.16 μM, and
the latter having a value of 2.01 μM. Unfortunately, the compounds also had IC50 values of 0.56
μM and 4.69 μM respectively against human keratinocyte (HaCaT) cells, meaning the
compounds will also most likely be toxic to healthy human cells and not just cancerous cells.

Figure 1.8 Chemical structures of (−)-(1R,2R,6R,8S,6’S)-discorhabdin B dimer (left) and
(−)-(1S,2R,6R,8S,6’S)-discorhabdin B dimer (right).15
With sponges, particularly Antarctic sponges, presenting such a wealth of novel
secondary metabolites, this brings us to the subject of this thesis; Suberites sp. Members of the
Suberites genus of sponges are found all over the world, such as S. aurantiacus native to the
Mexican Pacific,16 S. diversicolor found near Indonesia,17 or S. carnosus which is native to the
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waters around Ireland.18 Suberites sp. is a member of this genus that finds its home off the
coast of Antarctica. In 1995, this species of sponge was found to produce a pair of novel natural
products called suberitenone A and suberitenone B.19 Later, in 2004, two additional members
of the suberitenone family of compounds were successfully extracted from these sponges:
suberitenone C and suberitenone D.20 The suberitenones, classified as sesterterpenes, have
similar chemical structure to known cytotoxic and antimicrobial sponge metabolites. However,
when tested, it was found that they were lacking in bioactivity. Due to their similarity in
structure to known bioactive compounds, though, it has been hypothesized that suberitenones
could potentially be modified through chemical synthesis to augment their bioactivity.
Additionally, suberitenone B was found to be an inhibitor of cholesterol ester transfer protein
(CETP), which plays a major role in atherosclerotic diseases.19 As such, it has been proposed
that suberitenone B, or perhaps a derivative thereof, could be utilized in the treatment of
atherosclerosis and other related illnesses.
In this thesis, focus will be on suberitenone A and suberitenone B (Figure 1.9). Their
bioactivity will be assessed in a number of infectious disease assays, including the so-called
ESKAPE pathogens, a group of pathogens known for being resistant to antibiotic treatments as
well as being highly infectious; the acronym ESKAPE is derived from the scientific names of
these pathogens: Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.
Further, suberitenones will be tested against Plasmodium, a group of parasites that cause
malaria, and species of the fungal genus Candida.

10

Figure 1.9 Chemical structures of suberitenone A (left) and suberitenone B (right).19
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Chapter 2: Chemical Investigation of Suberites sp.
2.1 Medical impact of sponge metabolites
Sponges have played a vital role in the discovery and development of bioactive
compounds. Since the 1960’s, marine natural products alone have been the source of over
20,000 bioactive natural products. Of those compounds, a majority of them have been isolated
from sponges.21 As certain viruses, bacteria, and fungi become more resistant to conventional
means of treatment, alternative forms of treatment become more and more sought after, with
natural products being one such alternative. With sponges being such a prolific source of
natural products, and Antarctic species displaying such varied biodiversity, a great deal of
research has gone into the investigation of Antarctic sponges.
To this end, Suberites sp. has been investigated on more than one occasion. This species
of sponge produces the family of compounds known as suberitenones. Due to their structural
similarities to known bioactive compounds, they present potential for medicinal use either in
and of themselves or as the framework for chemical derivatives. Shin et al. specifically focused
on suberitenones A and B due to A’s potential for synthetic modification and B’s inhibition of
CETP. The objective of this thesis will be to expand upon this research, testing the activity of
these compounds against various illnesses and pathogens, including malaria, Candida, and the
ESKAPE pathogens.
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2.2 Experimental Procedure
The sponges were initially gathered from the waters around Palmer Station, Antarctica.
The specimens were frozen upon harvesting, and later lyophilized to prepare them for
extraction (Figure 2.1). The extraction process consisted of first chopping the freeze-dried
sponges into fine pieces. These pieces were then fully submerged in a solution of equal parts
methanol and dichloromethane (DCM). The sponge material was then left to steep in the
solvent for twenty-four hours before then being filtered. The filtered solvent was dried under
air to yield a crude extract, while the sponge material was submerged in fresh solvent to repeat
the process. This steeping process was done a total of three times or until the solvent no longer
picked up any color from the sponge, with each batch of filtered solvent being combined with
the last.

Figure 2.1 A freeze dried Suberites sp. (Sample PSC18-106 from lab of Dr. Bill Baker,
photo taken by Jared Waters with permission)
Once the crude extract was dried, it was purified using NMR (Nuclear Magnetic
Resonance)-guided fractionation. This started with dissolving the crude extract in hexane and
then washing the hexane solution in a separatory funnel with 10% aqueous methanol. The
13

hexane and aqueous methanol fractions were then separated and dried under air. Following
this, the dried aqueous methanol fraction was dissolved in ethyl acetate and was then washed
in a separatory funnel with water. Once again, they were separated and dried under air.
This then led into the next stage of purification: Medium Pressure Liquid
Chromatography (MPLC). The ethyl acetate fraction from the previous step was loaded onto a
silica column and fractionated via normal phase MPLC with UV (Ultraviolet) and ELS
(Evaporating Light Scattering) detectors using a gradient of ethyl acetate and hexane. The
resulting MPLC fractions were then dried under air and NMR spectra were obtained for each of
them. These NMR spectra were used to select which fractions contained relevant compounds
and would go on to further purification.

14

Scheme 2.1 Extraction scheme for Suberites sp. (sample PSC18-106)
Those fractions that were found to contain suberitenones were then subjected to the
final stage of purification: normal phase High Performance Liquid Chromatography (HPLC) with
a silica semi-prep column and a gradient of hexane and ethyl acetate. Once fractionated further
via this method, the fractions were dried under air and NMR spectra were obtained of each.
Based on these NMR spectra, it could be determined which fractions were pure suberitenones.

15

These pure compounds could then be submitted for bioassay against Candida, malaria, and the
ESKAPE pathogens.
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Chapter 3: Results and Conclusions
3.1 Experimental Data
Once the NMR spectra of the MPLC fractions had been obtained, it was determined that
fraction H contained suberitenone A, while fractions I through M contained varying
concentrations of suberitenone B. This was based on a number of noteworthy peaks in the
NMR spectra. These include, but are not limited to, a doublet of doublets found at
approximately 6.7 ppm which corresponds to the vinylic proton found on carbon 21 (see Figure
3.1), a broad singlet at approximately 5.5 ppm corresponding to the proton of carbon 6, and a
doublet of doublets at 2.7-2.8 ppm corresponding to the protons of carbon 24. Furthermore,
suberitenone A could be distinguished from suberitenone B based on the presence of a broad
singlet at approximately 5.2 ppm corresponding to the second vinylic proton found only in
suberitenone A on carbon 14, as opposed to a doublet of doublets at roughly 4.7 ppm found
only in suberitenone B corresponding to carbon 20. Fraction H was isolated at approximately
30% ethyl acetate in hexane, while fractions I through M were isolated from 40% to 50% ethyl
acetate in hexane. These fractions were then moved on to the HPLC purification step.

17

Figure 3.1 Generic suberitenone structure with position numbering system used by Shin, et al.19
When MPLC fraction H was further purified via HPLC, pure suberitenone A was isolated
at approximately 45% ethyl acetate in hexane. The identity of the suberitenone A sample was
verified by comparing its 1H and 13C NMR values against those reported by Shin, et al.19 (Table
3.1). Meanwhile, for MPLC fractions I through M, pure suberitenone B was isolated at 55% ethyl
acetate in hexane. Again, the identity of this sample was verified through comparison to the
values reported by Shin, et al. (Table 3.2). Once these pure compounds were dried, masses
were obtained for each of them, with suberitenone A amounting to 20.6 mg, while
suberitenone B totaled to 11.6 mg.

18

Table 3.1 Comparison of experimental NMR values of suberitenone A to literature values.19
Suberitenone A
1H
NMR
Position Experimental Data
0.88 (m)
15 0.94 (s)
16 1.03 (s)
5
17
9
1.17 (m)
18
1.28 (m)
3 1.4 (m)
1.49 (m)
1.59 (m)
1
2
11
25 1.8 (m)
7 1.97 (m)
2.07 (m)
OAc
12 2.16 (m)
2.35 (dd)
19
24 2.71 (m)
20 4.34 (br s)
14 5.21 (br s)
6 5.52 (br s)
21 6.77 (m)

13C
NMR
Literature
Data
0.87 (ddd)
0.91 (s)
1 (s)
1.04 (d)
1.12 (s)
1.12 (br d)
1.17 (m)
1.19 (s)
1.38 (m)
1.38 (dd)
1.46 (m)
1.57 (m)
1.72 (m)
1.72 (m)
1.72 (m)
1.8 (br s)
1.94 (dd)
2.02 (m)
2.04 (s)
2.12 (m)
2.33 (dd)
2.64 (br d)
2.7 (dd)
4.3 (br d)
5.18 (br s)
5.49 (br d)
6.74 (br d)

Position
25
18
11
2
16
17
12
15
4
8
24
10
1
3
7
19
9
5
20
6
13
22
14
21
OAc
23

19

Experimental
Data

Literature
Data
14.2
15.6
17.4
17.5
18.5
21.9
23
23.3
30.2
32.9
34.1
34.9
36.9
37.2
41.5
44.3

45.8
56.2
56.9
63.8
70.6
131.4
137.3
139
142.2
170.3
199.8

15.58
17.32
17.49
18.47
21.82
22.95
23.22
30.1
32.85
34
34.86
36.89
37.18
41.46
44.23
44.23
45.75
56.13
56.8
63.75
70.59
131.32
137.21
138.92
142.13
170.3
199.76

Table 3.2 Comparison of experimental NMR values of suberitenone B to literature values.19
Suberitenone B
1H
NMR
Position Experimental Data
9 0.92 (m)
1.03 (m)
15
16 1.1 (s)
5

18
1.21 (m)
17 1.37 (s)
3
1.48 (m)
11
2
19
1
25
14
7
12

1.73 (m)

1.83 (s)
1.93 (m)
2.07 (m)

OAc

24
20
6
21

2.18 (m)
2.39 (m)
2.55 (m)
2.84 (dd)
4.69 (dd)
5.49 (m)
6.71 (dd)

13C
NMR
Literature
Data
0.84 (m)
0.88 (m)
0.9 (s)
0.99 (s)
1.02 (d)
1.07 (d)
1.11 (m)
1.12 (m)
1.18 (s)
1.24 (dd)
1.33 (s)
1.35 (m)
1.43 (m)
1.58 (m)
1.68 (m)
1.72 (m)
1.72 (m)
1.75 (m)
1.79 (br s)
1.85 (dd)
1.94 (dd)
2.02 (m)
2.04 (s)

Position
25
11
18
2
17
16
24
15
4
8
10
12
1
3
7
19
14
5
9
20
6
13
22
21
OAc

2.5 (dd)
2.81 (dd)
4.65 (dd)
5.45 (br d)
6.67 (dq)

23

20

Experimental
Data
15.6
16.8
17.2
18.6
21.9
22.6
23.1
32.9
33
34.1
34.3
37.2
37.9
41.9
44.3
47
48.1
53.6
56.7
58.8
64.3
70.7
73.5
137.4
141.5
170.7
200.8

Literature
Data
15.61
16.89
17.19
18.53
21.87
22.54
23.04
32.89
32.92
34.01
34.24
37.14
37.87
41.83
44.23
46.9
47.99
53.55
56.66
58.76
64.25
70.69
73.46
137.27
141.55
170.67
200.87

These samples were then dissolved in dimethyl sulfoxide in concentrations of 5 mg per
mL and then submitted to the labs of Dr. Lindsey Shaw and Dr. John Adams for bioassay against
the ESKAPE pathogens and malaria respectively, while our lab conducted the Candida bioassay.
Unfortunately, the suberitenones were found to have no activity against Candida, and their
activity against the ESKAPE pathogens was found to be negligible (Figure 3.1). However, the
results of the malaria bioassay were promising. The bioassay procedure consisted of first
preparing a 96-well plate. To do this, the leftmost column of the plate was occupied with, from
top to bottom, a 10 microgram per milliliter sample of suberitenone A, a 10 microgram per
milliliter sample of suberitenone B, a 100 nanogram per milliliter sample of suberitenone A, and
a 100 nanogram per milliliter sample of suberitenone B. These samples were then daughtered
out across the plate via serial dilution, with each well having half the concentration of the well
to its left. The rightmost column of the plate was occupied with two controls. The first was a 1
microgram per milliliter sample of dihydroartemisinin, a compound with known antimalarial
properties which, at that dosage, would have 100% inhibition against malaria. The second
control was pure dimethyl sulfoxide, the solvent used in the samples of each well.
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Figure 3.2 Graph provided by Dr. Shaw’s lab displaying the % Inhibition of suberitenones A and
B against ESKAPE pathogens.
Once the plate was prepared, these samples could then be tested against blood-stage
malarial strains, the varying concentrations and their resulting inhibition or lack thereof
allowing for the formation of an activity curve. Two strains of P. falciparum were used in the
bioassay. One strain, designated by Dr. Adams’ lab as NF54, was a wild-type strain originally
from Africa with no known resistance profiles to any known anti-malarial agents. The second
strain, designated as DD2, was a lab generated strain cultivated from another wild type
originally from southeast Asia. DD2 was cultivated to be resistant to certain known anti-malarial
compounds such as mefloquine, chloroquine, and pyrimethamine. Additionally, the
suberitenones were tested on J774 murine cell macrophages in order to ascertain their
cytotoxicity against mammalian cells.
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Table 3.3 Table provided by Dr. Adams’ lab of IC50 and cytotoxicity values of suberitenones
compared to known anti-malarial compounds.
Suberitenone IC50
Suberitenone Suberitenone
A
B
NF54 IC50
DD2 IC50
J774
Cytotixicity

NF54 IC50
DD2 IC50
J774
Cytotixicity

2.342

1.31

N/A

N/A

ug/mL

6.184
4.957
Control compound IC50
DHA
CHQ
0.001027

0.000703

0.001435

0.01224

0.6878

24.78

ug/mL

Once IC50 values for suberitenones A and B had been obtained along with cytotoxicity
information, this information was then compared to that of known anti-malarial compounds,
namely dihydroartemisinin (DHA) and chloroquine (Table 3.3). Against the NF54 Plasmodium
strain, it was found that the IC50 values of suberitenones A and B were higher than those of
DHA and chloroquine. However, though their toxicity to Plasmodium was lower than that of the
known antimalarial compounds, the cytotoxicity of the suberitenones against mammalian cells
was found to be lower than their toxicity to the parasite. Suberitenone A and B’s IC50 values
against mammalian cells were found to be 6.184 and 4.957 respectively. These values are
higher than that of DHA, making the suberitenones less toxic to humans than DHA is, however
they are lower than that of chloroquine. Taking the ratio of the suberitenones’ antimalarial
activity against their cytotoxicity, the selectivity index could be found, with suberitenone A
having a selectivity index of 0.379 while suberitenone B had a selectivity index of 0.264.
Meanwhile, the selectivity indexes of DHA and chloroquine against the NF54 strain are 0.0015
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and 0.00003 respectively. With this selectivity towards the Plasmodium parasite in mind, even if
suberitenones A and B aren’t as effective of an antimalarial treatment as DHA or chloroquine
and are more toxic to mammalian cells than chloroquine, they do still pose the possibility of
being an effective alternative means of treatment, or simply a noteworthy lead compound in
future antimalarial research. As for the DD2 strain, it proved difficult to ascertain its IC50 value.
The activity of the suberitenones against DD2 proved to be so low at certain concentrations,
that a full activity curve could not be formed and thus an accurate IC50 value could not be
obtained. With the suberitenones showing promising antimalarial activity against the NF54
strain, this bioassay will be conducted two more times in order to verify the accuracy of these
findings as well as to potentially complete the activity curve against the DD2 strain and obtain
an accurate IC50 value and selectivity index for that strain. This initial bioassay was conducted
specifically on blood-stage malaria, but should these findings prove accurate then suberitenone
A and B will move forward to the next stage of bioassay, that being against liver-stage malaria.
3.2 Conclusion
Sponges have presented a plethora of novel compounds that have made an impact on
the medical field. With some secondary metabolites presenting anti-cancer activity, others
acting as antibacterial agents, and still others being anti-fungal in nature, the many different
species of sponge hold a vast array of bioactive agents with far-reaching applications. Suberites
sp. is no exception. Though suberitenone A and suberitenone B’s antifungal and antiviral
activity have proved to be minimal, it presents potential as an antimalarial agent. This
bioactivity will be pursued further with liver-stage malaria bioassay. Beyond this, suberitenone
C and suberitenone D can be investigated. Additionally, the possibility of modifying any of these
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suberitenones via chemical synthesis could be a subject worth investigating. Whatever the case
may be, suberitenones lay the foundation for a host of potential medical applications.
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Appendix A: Supporting Information for Chapter 2
MPLC chromatograms, HPLC chromatograms, Carbon NMR spectra, and Proton NMR spectra
for sample PSC18-106.

Proton NMR Spectrum (600 MHz, CDCl3) of Suberitenone A
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Carbon NMR Spectrum (150 MHz, CDCl3) of Suberitenone A

Proton NMR Spectrum (600 MHz, CDCl3) of Suberitenone B
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Carbon NMR Spectrum (150 MHz, CDCl3) of Suberitenone B
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Normal Phase MPLC Chromatogram of PSC18-106 using 24 g silica RediSep column (Red: 254
nm detector, Purple: 280 nm detector, Orange: 200-780 nm detector, Green: Evaporative Light
Scattering Detector, Blue: Solvent gradient, Solvent A: hexane, Solvent B: ethyl acetate, FlowRate: 35 mL/min.) Fractions were selected based on NMR spectroscopy, with NMR values being
compared to those reported by Shin, et al19.
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Normal Phase HPLC Chromatogram of PSC18-106 Fraction H, using a semi-prep silica column
(Red: 280 nm detector, Pink: 254 nm detector, Blue: solvent gradient, Solvent A: hexane,
Solvent B: ethyl acetate, Flow-Rate: 4 mL/min.) Fractions were selected based on NMR
spectroscopy, with NMR values being compared to those reported by Shin, et al19.

Normal Phase HPLC Chromatogram of PSC18-106 Fraction I, using a semi-prep silica column
(Red: 280 nm detector, Pink: 254 nm detector, Blue: solvent gradient, Solvent A: hexane,
Solvent B: ethyl acetate, Flow-Rate: 4 mL/min.) Fractions were selected based on NMR
spectroscopy, with NMR values being compared to those reported by Shin, et al19.
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